Performance characteristics of DRI, CEDIA, and REMEDi systems for preliminary tests of amphetamines and opiates in human urine

Journal of Analytical Toxicology

Volumn 30, Issue 1, 2006, Pages 61-64

  Huang, Min Kun ^a   Dai, Yu Shan ^a   Lee, Choung Huei ^a   Liu, Chiareiy ^a   Tsay, Wen Ing ^a   Li, Jih Heng ^a  

^a Executive Yuan   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; CODEINE; METHAMPHETAMINE; MORPHINE; OPIATE DERIVATIVE; NARCOTIC AGENT; STREET DRUG;

ARTICLE; CONTROLLED STUDY; DRUG SCREENING; GAS CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; MASS SPECTROMETRY; URINALYSIS; COMPARATIVE STUDY; EVALUATION; METHODOLOGY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; URINE;

AMPHETAMINES; HUMANS; IMMUNOASSAY; NARCOTICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 33646181792     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/30.1.61     Document Type: Article

References (12)

1. J. D'Nicuola, R. Jones, B. Levine, and M.L Smith. Evaluation of six commercial amphetamine and methamphetamine immunoassays for cross-reactivity to phenylpropanolamine and ephedrine in urine. J. Anal. Toxicol. 16: 211-213 (1992).
2. S.D. Ferrara, L. Tedeschi, G. Prison, G. Brusini, F. Castagna, B. Bernardelli, and D. Soregaroli. Drugs-of-abuse testing in urine: Statistical approach and experimental comparison of immunochemical and chromatographic techniques. J. Anal. Toxicol. 18: 278-291(1994).
3. P. Kintz and C. Giroud. Immunoassay responses of MBDB. J. Anal. Toxicol. 21: 589-590 (1997).
4. D.P. Baker, M.S. Murphy, P.F. Shepp, V.R. Royo, M.E. Caldarone, B. Escoto, and S.J. Salamone. Evaluation of the Abuscreen® ONLINE assay for amphetamines on the Hitachi 737: comparison with EMIT and GC/MS methods. J. Forensic Sci. 40: 108-112 (1995).
5. V. Lekskulchai and C. Mokkhavesa. Evaluation of Roche Abuscreen® ONLINE amphetamine immunoassay for screening of new amphetamine analogues. J. Anal. Toxicol. 25: 471-475 (2001).
6. P.R. Stout, K.L. Klette, and R. Wiegand. Comparison and evaluation of DRI Methamphetamine, DRI Ecstasy, Abuscreen ONLINE Amphetamine, and a modified Abuscreen ONLINE Amphetamine Screening Immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine. J. Anal. Toxicol. 27: 265-269 (2003).
7. A.J. Barnes, I. Kirn, R. Schepers, E.T. Moolchan, L. Wilson, G. Cooper, C. Reid, C. Hand, and M.A. Huestis. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration. J. Anal. Toxicol. 27: 402-406 (2003).
8. J. Hsu, C. Liu, C.P. Hsu, W.I. Tsay, J.H. Li, D.L. Lin, and R.H. Liu. Performance characteristics of selected immunoassays for preliminary test of 3,4-methylenedioxymethamphetamine, methamphetamine, and related drugs in urine specimens. J. Anal. Toxicol. 27: 471-478 (2003).
9. L.A. Broussard and I. Hanson. Evaluation of DRI® enzyme immunoassays for drugs of abuse screening on the Cobas Mira. Clin. Lab. Sci. 10: 83-86 (1997).
10. D.M. Steinberg, L.J. Sokoll, K.C. Bowles, J.H. Nichols, R. Roberts, S.K. Schultheis, and C.M. O'Donnell. Clinical evaluation of Toxi-Prep: a semi-automated solid-phase extraction system for screening of drugs in urine. Clin. Chem. 43: 2099-2105 (1997).
11. B.H. Chen, E.H. Taylor, and A.A. Pappas. Comparison of derivatives for determination of codeine and morphine by gas chromatography/mass spectrometry. J. Anal. Toxicol. 14: 12-17 (1990).
12. H. Zhao, R. Brenneisen, A. Scholar, A.J. McNally, M.A. ElSohly, T.P. Murphy, and S.J. Salamone. Profiles of urine samples taken from ecstasy users at rave parties: analysis by immunoassays, HPLC, and GC-MS. J. Anal. Toxicol. 25: 258-269 (2001).